Fred Parietti

Bet, let me tell you something about Fred Parietti, this guy is the real deal in biotech and robotics. So, Fred’s been all over the place academically and professionally, right? He went to MIT for his PhD in Mechanical Engineering, where he crushed it on autonomous robotic systems. Dude’s got a ton of creds, published 16 papers, owns 9 patents, and even snagged awards like the MIT De Florez Design Award. Before MIT, he was grinding at Carnegie Mellon, ETH Zurich, and the Polytechnic University of Milan, top schools, top research. Basically, he’s been deep in the robotics game forever, always pushing the envelope.

But here’s where it gets super interesting. Instead of just doing academic stuff, Fred jumped into startups. He co-founded Multiply Labs after going through Y Combinator’s Summer 2016 batch, which is a huge deal. Multiply is all about using robotics to change pharma manufacturing, think personalized meds, cell therapies, all that high-tech stuff that’s super hard to produce at scale. The company’s not just a small project; it’s raised major funding from YC, Lux Capital, Casdin Capital, big names, huge belief in what Fred and his team are doing.

So what does this say about him? Fred’s not just a nerd who loves robots, he’s a visionary who wants to change healthcare for good. His whole process screams one thing: he’s driven by a passion to make complex, life-saving treatments accessible and expandable. His background in advanced robotics and his entrepreneurial hustle show he’s all about building stuff that matters, stuff that can actually hit the world and make a difference.

Fred leads a super talented, multidisciplinary team in SF, working on robotic systems that could totally shake up pharma manufacturing. His story is about taking his deep tech expertise and turning it into real-world solutions that can save lives. No Cap, this guy’s process is a masterclass in blending hardcore science with startup grit. That’s why he’s so important, he’s not just building cool robots, he’s building the future of medicine.